We are thrilled to announce that our CEO, Núria Romero, has been featured in the 2023 AseBio Report. As AseBio celebrates its 25th anniversary, it has solidified its role as a key player in the growth and development of the biotechnology sector in Spain. Over the past quarter-century, AseBio has been instrumental in addressing industry challenges and driving future opportunities.
In her interview, Núria reflects on Asphalion’s incredible journey over the last 25 years as a leader in regulatory, scientific, pharmacovigilance, and Medtech consulting. Since its founding, Asphalion has maintained an unwavering commitment to innovation, excellence, and adaptability in an ever-changing industry.
As Núria highlights, “With a clear vision and dedication to excellence, Asphalion continues to be a trusted partner, leading the way toward a brighter and more promising future.”
Looking ahead to our 25th anniversary next year, Asphalion remains at the forefront, delivering cutting-edge solutions, embracing emerging technologies, and advancing healthcare on a global scale.
Read Núria’s full interview in the AseBio Report 2023 (page 49) and discover the remarkable evolution of the biotechnology industry in Spain!
For more information, please contact us at [email protected].
